Showing results (1891-1900 of 3,707) with videos related to
Sort By:
Pageof 371
Pathology|October 11, 2020
Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infectionKyra Y L Chua, Sara Vogrin, Intissar Bittar, et al.Pathology|June 1, 2022
PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structuresJoanna K M Ng, Paul C L Choi, Chit Chow, et al.Pathology|June 13, 2022
Mixed epithelial and stromal tumours of the kidney with malignant transformation: a clinicopathological study of four casesAnna Caliò, Liang Cheng, Guido Martignoni, et al.Pathology|June 18, 2022
Circulation of enterovirus D68 (EV-D68) causing respiratory illness in New South Wales, Australia, between August 2018 and November 2019Sacha Stelzer-Braid, Malinna Yeang, Philip N Britton, et al.Pathology|January 3, 2021
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretationElizabeth C Paver, Wendy A Cooper, Andrew J Colebatch, et al.Pathology|May 29, 2021
Expression of BCL6 in paediatric B-cell acute lymphoblastic leukaemia and association with prognosisArtturi Mäkinen, Atte Nikkilä, Juha Mehtonen, et al.Pathology|September 8, 2016
The concordance of serial ANA tests in an Australian tertiary hospital pathology laboratoryAdrian Y S Lee, Andrew R Hudspeth, Stephen AdelsteinPathology|October 27, 2021
ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1Timothy Fielder, Jordan Butler, Geraldine Tierney, et al.Pathology|January 25, 2022
High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case seriesMichał Kunc, Rafał Pęksa, Gabor Cserni, et al.Pageof 371